Related Experiment Videos
Indeterminate leprosy: a therapeutic evaluation.
Indian Journal of Leprosy
|April 1, 1992
Summary
Indeterminate leprosy requires multidrug therapy until all signs of activity subside. This study found that while many patients improved, some required extended treatment for complete lesion inactivity.
Area of Science:
- Dermatology
- Infectious Diseases
- Microbiology
Background:
- Indeterminate leprosy presents a diagnostic challenge.
- Early detection and treatment are crucial for preventing disease progression.
Purpose of the Study:
- To evaluate the treatment outcomes of indeterminate leprosy patients receiving multidrug therapy.
- To determine the duration of treatment required for complete lesion inactivity.
Main Methods:
- A cohort of 50 indeterminate leprosy cases were treated with multidrug therapy for one year.
- Clinical assessment of lesion activity was performed at baseline, six months, and one year.
Main Results:
- The majority of patients (76%) presented with a single hypopigmented macule.
- After one year of multidrug therapy, 66% of patients achieved inactive lesions, while 6% remained active.
- 24% of cases showed persistent lesion activity at the six-month follow-up.
Conclusions:
- Multidrug therapy is effective for indeterminate leprosy.
- Treatment should continue until all clinical signs of activity have resolved.
- Extended treatment duration may be necessary for some individuals.